<p>*—quintiles of distribution of entire patient groups, i.e., for all stages (0—lowest, 4—highest)</p><p>**—chemotherapy (Che), radiation therapy (Rad), and surgery (Sur)</p><p><sup>§</sup>-there are some minor inconsistencies in the recorded T and N statuses and respective AJCC stage (e.g., T3N0 should be stage II; T1-3N0 would be either stage I or stage II, not IIIA).</p><p>Values in brackets are percents of all patients (for Stage, i.e., first line of the Table) or stage-specific cohorts of patients.</p><p>Demographic, tumor, socio-economic characteristic and treatment modes for lung cancer patients with stages I, II, IIIA, IIIB, and IV.</p
BACKGROUND: Clinical staging of non-small cell lung cancer (NSCLC) helps determine the prognosis and...
Introduction:Management of Stage III non–small-cell lung cancer (NSCLC) involves surgery, radiothera...
<p>Clinical demographic data of 1522 lung cancer patients stratified by treatment interval from surg...
BACKGROUND Treatment of stage IIIA lung cancer remains controversial because it includes a very h...
BACKGROUND Treatment of stage IIIA lung cancer remains controversial because it includes a very h...
BACKGROUND Treatment of stage IIIA lung cancer remains controversial because it includes a very h...
BACKGROUND Treatment of stage IIIA lung cancer remains controversial because it includes a very h...
IntroductionWe evaluated treatment patterns of elderly patients with stage IIIA (N2) non–small-cell ...
INTRODUCTION: We evaluated treatment patterns of elderly patients with stage IIIA (N2) non-small-c...
Introduction:The role of surgery in addition to chemotherapy and radiation for stage IIIA non–small-...
Introduction:Management of Stage III non–small-cell lung cancer (NSCLC) involves surgery, radiothera...
<p>The Kaplan-Meier plots show the difference between low- and high-risk groups as determined by the...
Based on clinical assessment alone, patients with stage II non-small cell lung cancer (NSCLC) compri...
Purpose:To assess the impact of cell type, age, and gender in addition to pathologic tumor, node, me...
<p>*Sub-stages for stage I and II patients are combined as it was not possible to differentiate betw...
BACKGROUND: Clinical staging of non-small cell lung cancer (NSCLC) helps determine the prognosis and...
Introduction:Management of Stage III non–small-cell lung cancer (NSCLC) involves surgery, radiothera...
<p>Clinical demographic data of 1522 lung cancer patients stratified by treatment interval from surg...
BACKGROUND Treatment of stage IIIA lung cancer remains controversial because it includes a very h...
BACKGROUND Treatment of stage IIIA lung cancer remains controversial because it includes a very h...
BACKGROUND Treatment of stage IIIA lung cancer remains controversial because it includes a very h...
BACKGROUND Treatment of stage IIIA lung cancer remains controversial because it includes a very h...
IntroductionWe evaluated treatment patterns of elderly patients with stage IIIA (N2) non–small-cell ...
INTRODUCTION: We evaluated treatment patterns of elderly patients with stage IIIA (N2) non-small-c...
Introduction:The role of surgery in addition to chemotherapy and radiation for stage IIIA non–small-...
Introduction:Management of Stage III non–small-cell lung cancer (NSCLC) involves surgery, radiothera...
<p>The Kaplan-Meier plots show the difference between low- and high-risk groups as determined by the...
Based on clinical assessment alone, patients with stage II non-small cell lung cancer (NSCLC) compri...
Purpose:To assess the impact of cell type, age, and gender in addition to pathologic tumor, node, me...
<p>*Sub-stages for stage I and II patients are combined as it was not possible to differentiate betw...
BACKGROUND: Clinical staging of non-small cell lung cancer (NSCLC) helps determine the prognosis and...
Introduction:Management of Stage III non–small-cell lung cancer (NSCLC) involves surgery, radiothera...
<p>Clinical demographic data of 1522 lung cancer patients stratified by treatment interval from surg...